The short answer
Two daily GLP-1 pills are FDA-approved for weight management: the Wegovy pill (oral semaglutide 25 mg, approved Dec. 22, 2025) and Foundayo (orforglipron, approved April 1, 2026). The Wegovy pill must be taken on an empty stomach with up to 4 ounces of water and a 30-minute wait, while Foundayo can be taken any time with or without food. Both start at $149 a month self-pay and are covered for eligible people by the $50 Medicare GLP-1 Bridge.
This guide is educational and not medical advice. It does not give dosing instructions. Talk to your prescriber or pharmacist about your own situation.
Rybelsus, an older oral semaglutide, is approved for type 2 diabetes, not weight management.
| Wegovy pill | Foundayo | |
|---|---|---|
| Active ingredient | Semaglutide (same as Wegovy/Ozempic injections) | Orforglipron |
| How to take | Once daily on an empty stomach in the morning with up to 4 oz of water; wait at least 30 minutes before eating, drinking or other oral medicines | Once daily, any time of day, with or without food; swallow whole |
| Key trial result | −13.6% body weight at 64 weeks vs −2.4% placebo (25 mg, label Study 7) | −12.4% at 72 weeks on the highest dose vs −0.9% placebo for those who stayed on treatment; −11.1% vs −2.1% regardless of adherence (ATTAIN-1) |
| Most common side effects | Nausea, diarrhea, vomiting, constipation, abdominal pain and other GI effects (label: most common, ≥5%) | Nausea (26–35%), constipation, diarrhea, vomiting, indigestion; hair loss listed |
| Self-pay price (Oct. 2026) | $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) via NovoCare | $149 (0.8 and 2.5 mg), $199 (5.5 mg), $299 (9, 14.5, 17.2 mg) via LillyDirect; some prices temporary to Dec. 31, 2026 |
| With commercial coverage | As little as $25 (max $100/month savings) | As little as $25 |
| Medicare GLP-1 Bridge | Covered, $50/month if eligible | Covered, $50/month if eligible |
Trial results come from different studies with different designs and populations, so they can’t be compared head-to-head.
In their labels, the Wegovy pill (25 mg) averaged 13.6% weight loss at 64 weeks and Foundayo’s highest dose about 12% among people who stayed on treatment, while the Wegovy 2.4 mg injection and Zepbound produced their own results in separate trials. None of the labels includes a head-to-head trial comparing the pills with each other or with the injections. Your prescriber can help weigh effectiveness, side effects, routine and cost.
People who don’t want injections, who travel and want to avoid refrigerated pens, or who prefer a daily routine. The Wegovy pill’s empty-stomach rule suits some mornings and not others; Foundayo has no food or water restrictions. A pill is still a GLP-1, so expect the same kinds of side effects and the same need for protein, fluids and strength training.
Lilly says birth control pills may not work as well while taking Foundayo and that your provider may recommend another method for 30 days after starting and after each dose increase. Tell your care team you take any GLP-1 before surgery or sedation; the labels warn about the risk of food getting into the lungs during procedures.
Both require a prescription. Lilly sells Foundayo through LillyDirect (home delivery or retail pickup) and says it’s also available through U.S. retail pharmacies and telehealth providers. Novo Nordisk sells the Wegovy pill through NovoCare Pharmacy and local pharmacies with its savings offer. Telehealth services in our directory prescribe brand-name GLP-1s only—we don’t list compounded sellers.
Possibly, but it’s a prescriber decision. Lilly’s Foundayo FAQ says to consult your doctor about the transition and dosing, and the label says Foundayo shouldn’t be used with other GLP-1 receptor agonist medicines. Don’t combine or switch GLP-1s on your own.
Yes. The FDA approved the Wegovy pill (oral semaglutide 25 mg) on Dec. 22, 2025 and Lilly’s Foundayo (orforglipron) on April 1, 2026. Both are once-daily tablets for chronic weight management alongside diet and activity.
They contain different active ingredients. The Wegovy pill (semaglutide) must be taken on an empty stomach with up to 4 oz of water and a 30-minute wait before eating; Foundayo (orforglipron) can be taken any time with or without food. Both start at $149 a month self-pay.
In October 2026, the Wegovy pill costs $149–$299 a month self-pay through NovoCare and Foundayo $149–$299 through LillyDirect. With commercial coverage, savings cards can bring either to as little as $25; eligible Medicare Part D enrollees pay $50.
Yes, for eligible people with Medicare Part D through the Medicare GLP-1 Bridge (July 1, 2026–Dec. 31, 2027), with a $50 monthly copay. Eligibility depends on BMI and certain health conditions, and prior authorization is required.
The Wegovy label says to take the tablet on an empty stomach in the morning with up to 4 ounces of plain water only, then wait at least 30 minutes before eating, drinking anything else (including coffee) or taking other oral medicines. Foundayo has no food or drink restrictions.
Eli Lilly's direct-to-patient pharmacy for Zepbound, Foundayo, and other Lilly medicines, with home delivery.
Why it helps on a GLP-1: Self-pay Zepbound vials and KwikPens start at $299/month for the starter dose, and Foundayo pills start at $149/month—no insurance needed (prescription required).
Novo Nordisk's own pharmacy for self-pay Wegovy (pen and pill) and Ozempic, delivered to your door.
Why it helps on a GLP-1: New patients pay $199/month for the first two fills of the two lowest Wegovy pen doses (through 12/31/2026), then $349/month; Wegovy pill starts at $149/month.
Federal website listing negotiated cash prices for brand-name GLP-1s and linking to each maker's program.
Why it helps on a GLP-1: A quick way to compare starting cash prices for Wegovy, Ozempic, Zepbound, and Foundayo in one place. It doesn't sell drugs itself.
Temporary Medicare program (from July 1, 2026) covering Wegovy, Zepbound KwikPen, and Foundayo for eligible Part D enrollees.
Why it helps on a GLP-1: Eligible people with Medicare drug coverage pay a $50 monthly copay. Check the BMI and health-condition criteria on Medicare.gov.
Medication reminder and tracking app.
Why it helps on a GLP-1: Helps you remember a weekly shot or daily pill and log doses.
Browse related categories: 💸 Savings 🩺 Telehealth 📱 Apps
Official Oct 2026 self-pay prices for Zepbound and Wegovy (plus the Wegovy pill and Foundayo), what changes the price, and cheaper paths if you qualify.
Read the guide →MedicareThe Medicare GLP-1 Bridge (July 2026–Dec 2027) in plain English: covered drugs, BMI and health criteria, who is excluded, the $50 copay and how to start.
Read the guide →Getting startedA practical, no-dosing checklist for your first month on Zepbound, Wegovy, Ozempic, Mounjaro or a GLP-1 pill: questions, cost, food, side effects.
Read the guide →Prices and program terms change often; we re-check them on the official pages listed above. Listings are not endorsements, and we never list compounded semaglutide or tirzepatide sellers. Spot something outdated? Email hello@glp1sidekick.com.